Getinge's Q3 Surprise: Ventilators Surge, Outlook Steady

Getinge stuns the market with a knockout Q3, shares surge! Discover how they defied expectations with nearly 10% organic sales growth, driven by ventilator demand and Life Sciences' explosive 15% rise. Uncover the secrets behind their 90-point gross margin leap and what it means for their ambitious 2025 and beyond targets. Is Getinge on track to dominate, or will Q4's challenges temper their victory?The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.